BPC-157 research demonstrates benefits across multiple tissue types: bone, muscle, tendon, ligament, and connective tissue
Canada will be a launching pad in the global race for generic Ozempic How is everyone getting Ozempic prescriptions so easily
The FDA approved its first interchangeable biosimilar, Cyltezo (adalimumab-adbm), in July 2021, and the category has grown since but remains operationally more difficult to achieve than basic biosimilar approval
Gene Ther
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect
Compounded NAD Injections can be administered via IV (intravenous), IM (intramuscular) or SC (subcutaneous) route